Review
Published on 09 Jan 2024
Machine learning in onco-pharmacogenomics: a path to precision medicine with many challenges
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1260276
- 3,657 views
- 4 citations
Type at least 3 characters
551 articles
Articles
Original Research
Published on 08 Jan 2024
CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1334440
- 1,474 views
- 1 citation
Original Research
Published on 03 Jan 2024
Transcriptomic and metabolomic analysis of peri-tumoral hepatic tissue in hepatocellular carcinoma: unveiling the molecular landscape of immune checkpoint therapy resistance
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1304996
- 1,264 views
Case Report
Published on 03 Jan 2024
Organ-specific immune-mediated reactions to polyethylene glycol and polysorbate excipients: three case reports
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1293294
- 1,976 views
- 1 citation
Review
Published on 12 Dec 2023
Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1326682
- 2,106 views
- 2 citations
Review
Published on 11 Dec 2023
Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1303844
- 2,893 views
- 3 citations
Review
Published on 01 Dec 2023
Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1286494
- 3,260 views
- 1 citation
Original Research
Published on 28 Nov 2023
miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1275238
- 1,507 views
Original Research
Published on 22 Nov 2023
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1294873
- 1,728 views
Brief Research Report
Published on 17 Nov 2023
Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1278769
- 2,326 views
- 2 citations
Original Research
Published on 15 Nov 2023
Human N-acetyltransferase 2 (NAT2) gene variability in Brazilian populations from different geographical areas
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1278720
- 2,249 views
- 1 citation
Original Research
Published on 15 Nov 2023
Construction of a risk scoring system using clinical factors and RYR2 polymorphisms for bleeding complications in patients on direct oral anticoagulants
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1290785
- 1,154 views
- 1 citation
Methods
Published on 14 Nov 2023
Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1274165
- 2,494 views
Original Research
Published on 13 Nov 2023
Targeted haplotyping in pharmacogenomics using Oxford Nanopore Technologies’ adaptive sampling
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1286764
- 5,875 views
- 4 citations
Case Report
Published on 09 Nov 2023
HLA-targeted sequencing reveals the pathogenic role of HLA-B*15:02/HLA-B*13:01 in albendazole-induced liver failure: a case report and a review of the literature
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1288068
- 1,383 views
- 3 citations
Original Research
Published on 06 Nov 2023
CYP450 and drug efflux transporters polymorphism influence clinical outcomes of Thai osimertinib-treated non-small cell lung cancer patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1222435
- 2,302 views
- 5 citations